Lynx1 Capital Management LP: insider buys

Every open-market stock purchase reported by Lynx1 Capital Management LP to the SEC on Form 4.

Total bought$16.33M

Purchases6

Companies4

Last purchase filedOct 26, 2026

Return on these buys+77%

Lynx1 Capital Management LP has made 6 open-market purchases worth $16.33M in 4 companies since Oct 10, 2025, according to SEC Form 4 filings. The most recent was filed on Oct 26, 2026: 79,809 shares of KRRO at $11.09 (10% Owner), worth $884.75K. The largest was $9.83M of CGEM on Oct 8, 2025. Taken together, these purchases are up 77% at the latest closing prices (split-adjusted, weighted by amount).

Companies Lynx1 Capital Management LP bought

Ticker	Company	Role	Buys	Total	Since buy	Last filed
CGEM	Cullinan Therapeutics, Inc.	10% Owner	2	$11.93M	+115%	Oct 21
NEUP	Neuphoria Therapeutics Inc.	10% Owner	1	$3.29M	-41%	Oct 23
KRRO	Korro Bio, Inc.	10% Owner	2	$963.57K	+28%	Oct 26
TCRX	TScan Therapeutics, Inc.	10% Owner	1	$145.62K	-81%	Dec 23

Get the next Lynx1 Capital Management LP purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All purchases

Filed	Stock	Insider	Value	Shares	Price	Since buy	Stake	Trade
Oct 26	KRROKorro Bio, Inc.	Lynx1 Capital Management LP +110% Owner	$884.75K	79,809	$11.09	+29%	+5%	Oct 22	SEC
Aug 13	KRROKorro Bio, Inc.	Lynx1 Capital Management LP +110% Owner	$78.81K	6,684	$11.79	+21%	+0%	Aug 6	SEC
Dec 23	TCRXTScan Therapeutics, Inc.	Lynx1 Capital Management LP +110% Owner	$145.62K	161,801	$0.90	-81%	+2%	Dec 19	SEC
Oct 23	NEUPNeuphoria Therapeutics Inc.	Lynx1 Capital Management LP +110% Owner	$3.29M	639,110	$5.14	-41%	+271%	Oct 21	SEC
Oct 21	CGEMCullinan Therapeutics, Inc.	Lynx1 Capital Management LP +110% Owner	$2.10M	248,749	$8.46	+78%	+3%	Oct 14	SEC
Oct 10	CGEMCullinan Therapeutics, Inc.	Lynx1 Capital Management LP +110% Owner	$9.83M	1,459,641	$6.73	+123%	+21%	Oct 8	SEC